Ex Vivo Expansion of Human Cord Blood Stem Cells and Its Application to Gene Therapy

スポンサーリンク

概要

• 論文の詳細を見る
• 1999-01-01

著者

• Kawada Hiroshi

  Research Center for Regenerative Medicine, Tokai University School of Medicine

• Hotta Tomomitsu

  Research Center for Regenerative Medicine, Tokai University School of Medicine

• Hotta Tomomitsu

  National Hospital Organization Nagoya Medical Center

• Hotta Tomomitsu

  東海大学 医学研究科血液腫瘍内科

• ANDO Kiyoshi

  Tokai University

• Hotta T

  National Hospital Organization Nagoya Medical Center

• Kijima H

  Tokai Univ. School Of Medicine Kanagawa Jpn

• Kato Shunichi

  Department Of Pediatrics

• Kawada Hiroshi

  Department Of Hematology/oncology Tokai University School Of Medicine

• ANDO Kiyoshi

  Research Center for Genetic Engineering and Cell Transplantation, Tokai University School of Medicin

• Hata Tomoko

  Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi

• KATO Shunichi

  Research Center for Genetic Engineering and Cell Transplantation

• SHIMIZU Takashi

  Research Center for Genetic Engineering and Cell Transplantation

• TSUJI Takashi

  The Division of Hematology, Pharmaceutical Frontier Research Laboratory, JT Inc.

• Hirabayashi Kenichi

  Department Of Pathology Tokai University School Of Medicine

• Ando Kiyoshi

  Division Of Hematology/oncology Department Of Internal Medicine

• Kikuchi Ako

  Department Of Hematology/oncology Tokai University School Of Medicine

• Kikuchi Ako

  Tokai University

• Hayashi Tomayoshi

  National Hospital Organization Nagoya Medical Center

• Hotta Tomomitsu

  Research Center For Genetic Engineering And Cell Transplantation

• Kijima Hiroshi

  Department Of Hematology/oncology Tokai University School Of Medicine

• Kawada Hiroshi

  Research Center For Genetic Engineering And Cell Transplantation

• Kanamaru Akihisa

  Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine

• Tsuji Takashi

  The Division Of Hematology Pharmaceutical Frontier Research Laboratory Jt Inc.

• Shimizu Takashi

  Department Of Pediatrics

関連論文

• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
• ＜Symposium I＞Vascular endothelial growth factor（ VEGF） expression is negatively regulated by basic-helix-loop-helix（ bHLH）transcription factor DEC2
• An Up-to-Date Anti-Cancer Treatment Strategy Focusing on HIF-1α Suppression : Its Application for Refractory Ovarian Cancer
• Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
• Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• PE-397 Bone marrow-derived regenerated cardiomyocytes after myocardial infarction were not originated from hematopoietic stem cells(Apoptosis/Necrosis/Regeneration 2 (M) : PE68)(Poster Session (English))
• Transplanted Bone Marrow Stem Cells Move to the Infarcted Myocardium and Regenerate the Heart
• Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
• Transplantation of Mesenchymal Stem Cells to Prevent Radiation-induced Intestinal Injury in Mice
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
• No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
• Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci
• Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
• Successful cord blood transplantation for mycosis fungoides.
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
• Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
• Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
• A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
• Pulmonary non-caseating granuloma in Waldenstrom macroglobulinemia
• Relationship between gastric mucosal IL-8 levels and histological gastritis in patients with Helicobacter pylori infection
• Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Prognostic Significance of FLT3 Internal Tandem Duplication and NPM1 Mutations in Acute Myeloid Leukemia in an Unselected Patient Population
• Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
• A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
• A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
• Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
• Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
• Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-Cell Leukemia Cells
• Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
• Multiple K-ras Mutations in Hyperplasia and Carcinoma in Cases of Human Pancreatic Carcinoma
• Advantages of immunostaining over DNA analysis using PCR amplification to detect p53 abnormality in long-term formalin-fixed tissues of human colorectal carcinomas
• Alteration of p53 Clonality Accompanying Colorectal Cancer Progression
• A Case Report: Spontaneous Rupture of Dissecting Aneurysm of the Middle Colic Artery
• An anti-K-ras ribozyme suppresses oncogene expression and cell growth of human pancreatic cancer
• Mechanisms of retinoid resistance in a myeloid cell line, YM711,transfected with PML/RARα cDNA : possible involvement of redox potential
• A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
• Changes in Microbial Flora in Neutropenic Patients With Hematological Disorders After the Hanshin-Awaji Earthquake
• Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation
• Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation
• Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients
• Detection of donor-type alveolar macrophages in transplantation with highly purified CD34^+ bone marrow cells
• Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation
• The in vivo development of human T cells from CD34^+ cells in the murine thymic environment
• Clonality analysis of granulocytes and T lymphocytes in healthy females by the PCR-based HUMARA method
• Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
• Immunohistochemical Mucin Expression of Short-Segment Barrett's Esophagus
• Extramedullary Blast Crisis Derived from 2 Different Clones in the Central Nervous System and Neck during Complete Cytogenetic Remission of Chronic Myelogenous Leukemia Treated with Imatinib Mesylate
• Follicular Lymphoma in Osaka, Japan : Histological Features and Chronological Change
• A Case of Hypoplastic Chronic Myelogenous Leukemia Initiating With Pancytopenia
• Clinical Effects of Infusing Anti-Epstein -Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes into Patients with Severe Chronic Active EBV Infection
• Comparison of Soluble and Membrane Bound HLA-Class I and DR Levels in Umbilical Cord Blood and Adult Peripheral Blood
• The Generation of Immunocompetent Dendritic Cells From CD34^+ Acute Myeloid or Lymphoid Leukemia Cells
• The Impact of HLA-A Matching in Corneal Transplantation
• Ex Vivo Expansion of Human Cord Blood Stem Cells and Its Application to Gene Therapy
• A simple and efficient purification of transduced cells by using green fluorescent protein gene as a selection marker
• Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer
• A Case for Gastrointestinal Stromal Tumor (GIST) with Reference to Its Ultrastructure and 'Gain-of-Function' Mutation
• Preliminary Study for Sentinel Lymph Node Identification with Tc-99m Tin Colloid in Patients with Esophageal or Gastric Cancer
• Possible involvement of the TGF-β1 signal in the development of peritoneal sclerosis as one of the major complications in continuous ambulatory peritoneal dialysis
• Serum KL-6 Levels in Patients With Pulmonary Complications After Allogeneic Bone Marrow Transplantation
• Ikk-i, a novel Lipopolysaccharide-inducible kinase that is realted to lκB Kinases
• Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
• IgD monoclonal gammopathy of undetermined significance
• Eosinophilic Colitis in a Patient with Acute Myeloid Leukemia after Allogeneic Bone Marrow Transplantation
• DUPLICATE GALLBLADDER DIAGNOSED WITH ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AND TREATED WITH LAPAROSCOPIC CHOLECYSTECTOMY
• Therapeutic strategy targeting the mTOR-HIF-1α-VEGF pathway in ovarian clear cell adenocarcinoma
• Transgene Insertion Pattern Analysis Using Genomic Walking in a Transgenic Mouse Line
• Perivascular epithelioid cell tumor (PEComa) of the pancreas : Immunoelectron microscopy and review of the literature
• Undifferentiated Spindle and Giant Cell Carcinoma of the Common Bile Duct
• Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
• Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
• Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
• Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
• Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
• The Relationship between Sperm Morphology and In Vitro Fertilization Ability in Mice
• Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
• The distance of tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm : where to resect and how to predict it
• Nonfunctioning Pancreatic Endocrine Tumor with Extension into the Main Pancreatic Duct : Report of a Case
• Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
• Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
• Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
• Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
• Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
• Leiomyosarcoma of the Pancreas : Report of a Case
• Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
• An annular pancreas associated with carcinoma of the papilla of Vater : report of a case
• An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
• Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
• Granulosa cell tumor with activated mTOR-HIF-1α-VEGF pathway
• Reaction process of vanadium tetrachloride with ammonia in the vapor phase and properties of the vanadium nitride formed.
• Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma : a retrospective analysis of the Nagasaki Transplantation Network

もっと見る 閉じる

スポンサーリンク